Pharmacyte Biotech Inc Net Income per Employee (PMCB), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Pharmacyte Biotech Inc   (NASDAQ: PMCB)
 

Pharmacyte Biotech Inc Net Income per Employee

PMCB's Quarterly Results, Trends, Rankings, Statistics
Pharmacyte Biotech Inc recorded a cumulative net loss of $-20 million during 12 month ending in the fourth quarter 2026.
The Healthcare sector has seen employees of 148 other companies achieving higher income per employee. While Pharmacyte Biotech Inc 's total ranking has deteriorated compared to the previous quarter from 2946 to 4606.


What is Income per Employee Ratio?






PMCB Net Income per Employee (Apr 30 2026)
IV. Quarter
(Jan 31 2026)
III. Quarter
(Oct 31 2025)
II. Quarter
(Jul 31 2025)
I. Quarter
(Apr 30 2025)
IV. Quarter
Y / Y Net Income Change - - - - 4346.11 %
Net Income per Employee (TTM) $ -9,809,876 -3,223,753 -5,070,618 -2,270,070 13,277,756
PMCB's Total Ranking # 4606 # 2946 # 3548 # 3168 # 29
Seq. Net Income Change - - - - -


PMCB Net Income per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 149
Healthcare Sector # 920
Overall Market # 4606

Net Income per Employee Statistics
High Average Low
$ 13,277,756 $ -902,876 $ -5,070,618
(Apr 30 2025)   (Oct 31 2025)







Companies with similar Income per Employee for 12 month ending Apr 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Apr 30 2026Number of Employees Apr 30 2026


Date modified: 2026-08-29T00:48:40+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.